Lv3
282 积分 2025-04-17 加入
Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies
2天前
已完结
Burosumab treatment for children younger than 12 months with X-linked hypophosphataemia
14天前
已关闭
Emerging Role of Letermovir, a CMV DNA Terminase Inhibitor, in the Management of Cytomegalovirus Retinitis: Efficacy, Safety, and Treatment Outcomes
16天前
已关闭
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
17天前
已完结
Impact of CMV Infection on Pediatric Allogeneic HSCT Outcomes in a Region of High CMV Seroprevalence: A Non-TBI Cohort Study
17天前
已关闭
A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis
25天前
已关闭
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
25天前
已完结
Changing scenario in prevention and management of CMV infections in pediatric hematopoietic stem cell transplant patients
25天前
已完结
Letermovir: First Global Approval
25天前
已完结
An overview of letermovir: a cytomegalovirus prophylactic option
25天前
已完结
皖公网安备34019202002308
